This year, the Expert Committee for the Selection and Use of Medicines will consider requests to include high-cost medicines for can -cer, hepatitis C, multidrug-resistant tu -berculosis and new oral anticoagulants on the model list. These applications challenge perceptions of essential medi -cines and raise questions about how to address issues of cost and affordability for countries when making decisions at the global level.Essential medicines are those that satisfy the priority health-care needs of the population.
No takes yet. Share an insight, caveat, or question.
Magrini et al. (2015) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: